Top Markets
Coin of the day
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.

GeneFerm Biotechnology Co., Ltd.

1796
Rangering i aksjer #26680
GeneFerm Biotechnology Co., Ltd. specializes in the development, production,... GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive product line includes a variety of microbial fermentation offerings such as different types of mushrooms, lactic acid bacteria, other bacterial strains, yeast, and algae. Furthermore, GeneFerm provides a wide array of bio-fermented ingredients, including specialized powders like nattomena, natto fermented powder, red yeast rice fermented powder, and various mycelial powders (e.g., antrodia cinnamomea, cordyceps, reishi, phellinus linteus, armillaria mellea). They also supply beta-glucan powder, fermented fruit and vegetable enzymes, as well as probiotic and peptide components. Beyond its product sales, GeneFerm offers additional services such as private label supplement manufacturing, packaging equipment, and expert microbial fermentation toll manufacturing and consulting. Established in 1988, the company maintains its headquarters in Tainan City, Taiwan.
Aksjekurs
$0.93330147
Markedsverdi
$38.69M
Endring (1 dag)
-1.01%
Endring (1 år)
-39.84%
Land
TW
Handel GeneFerm Biotechnology Co., Ltd. (1796)

Kategori

Inntekter for GeneFerm Biotechnology Co., Ltd. (1796)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til GeneFerm Biotechnology Co., Ltd. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for GeneFerm Biotechnology Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter